This inventor holds 1 USPTO granted patent. Top assignee: Sandoz Gmbh. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Jurg Reinhardt: Innovator in Interleukin Therapy
Introduction
Jurg Reinhardt is a notable inventor based in Ehrenkirchen, Germany. He has made significant contributions to the field of medical therapies, particularly in the area of interleukin treatment. His innovative work has the potential to impact patient care and therapeutic strategies.
Latest Patents
Jurg Reinhardt holds a patent for "Interleukin therapy - Interleukin-2 liposomes are advantageous sustained release formulations." This patent highlights his focus on developing effective delivery systems for interleukin therapies, which are crucial in treating various medical conditions.
Career Highlights
Reinhardt is currently employed at Sandoz GmbH, a company known for its commitment to providing high-quality generic pharmaceuticals. His role at Sandoz allows him to further his research and development efforts in the pharmaceutical industry.
Collaborations
Throughout his career, Jurg Reinhardt has collaborated with esteemed colleagues such as Thomas Kissel and Henriette Schrank. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Jurg Reinhardt's contributions to interleukin therapy exemplify the importance of innovation in the medical field. His work not only advances scientific knowledge but also holds promise for improving patient treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile